Registration of Intravenous Thrombolysis for Acute Ischemic Stroke in Southwestern China（IVTIS）

Last updated: November 26, 2023
Sponsor: Zhengzhou Yuan
Overall Status: Active - Recruiting

Phase

N/A

Condition

Blood Clots

Thrombosis

Cerebral Ischemia

Treatment

intravenous thrombolysis

Clinical Study ID

NCT06131385
SWMU-2023-12
  • All Genders

Study Summary

This study aims to observe the safety and effectiveness of intravenous thrombolysis for acute ischemic stroke in real-world clinical practice.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • The patient was diagnosed with acute ischemic stroke and received intravenousthrombolysis.

Exclusion

Exclusion Criteria:

  • No additional exclusion criteria.

Study Design

Total Participants: 3000
Treatment Group(s): 1
Primary Treatment: intravenous thrombolysis
Phase:
Study Start date:
November 20, 2023
Estimated Completion Date:
May 01, 2046

Study Description

IVTIS is a prospective, real-world registry lasting for 22 years. A total of 3000 patients with intravenous thrombolysis will be enrolled。

Connect with a study center

  • Affiliated Hospital of Southwest Medical University

    Luzhou, 646000
    China

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.